Henning R. Stennicke
Chief Tech/Sci/R&D Officer at FREELINE THERAPEUTICS HOLDINGS PLC
Henning R. Stennicke active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 2022-02-28 | - |
Career history of Henning R. Stennicke
Former positions of Henning R. Stennicke
| Companies | Position | Start | End |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | - | - |
Training of Henning R. Stennicke
| University of Copenhagen | Graduate Degree |
| Technical University of Denmark | Masters Business Admin |
Statistics
International
| Denmark | 4 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private companies | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Henning R. Stennicke
- Experience
